Florian Giesert

Florian Giesert

Auto-generated profile, based on publicly available information

Florian Giesert

Institute of Developmental Genetics, Helmholtz Munich, Oberschleißheim, Germany

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2011 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
GPGiovanni Piccoli
Giovanni Piccoli
SCSteven B. Condliffe
Steven B. Condliffe
MBMatthias Bauer
Matthias Bauer
FGFlorian Giesert
Florian Giesert
KBKarsten Boldt
Karsten Boldt
MUMarius Ueffing
Marius Ueffing
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the single most common cause of inherited Parkinson's disease. Little is known about its involvement in the pathogenesis of Parkinson's disease mainly because of the lack of knowledge about the physiological role of LRRK2. To determine the function of LRRK2, we studied the impact of short hairpin RNA-mediated silencing of LRRK2 expression in cortical neurons. Paired recording indicated that LRRK2 silencing affects evoked postsynaptic currents. Furthermore, LRRK2 silencing induces at the presynaptic site a redistribution of vesicles within the bouton, altered recycling dynamics, and increased vesicle kinetics. Accordingly, LRRK2 protein is present in the synaptosomal compartment of cortical neurons in which it interacts with several proteins involved in vesicular recycling. Our results suggest that LRRK2 modulates synaptic vesicle trafficking and distribution in neurons and in consequence participates in regulating the dynamics between vesicle pools inside the presynaptic bouton.

27 January 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AMA. Moretti
A. Moretti
LFL. Fonteyne
L. Fonteyne
FGF. Giesert
F. Giesert
PHP. Hoppmann
P. Hoppmann
AMA. B. Meier
A. B. Meier
CKChristian Kupatt
Christian Kupatt

1 March 2014 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
FPFrancesca Pischedda
Francesca Pischedda
JSJoanna Szczurkowska
Joanna Szczurkowska
MCMaria Daniela Cirnaru
Maria Daniela Cirnaru
FGFlorian Giesert
Florian Giesert
EVElena Vezzoli
Elena Vezzoli
GPGiovanni Piccoli
Giovanni Piccoli
A complex and still not comprehensively resolved panel of transmembrane proteins regulates the outgrowth and the subsequent morphological and functional development of neuronal processes. In order to gain a more detailed description of these events at the molecular level, we have developed a cell surface biotinylation assay to isolate, detect, and quantify neuronal membrane proteins. When we applied our assay to investigate neuron maturation in vitro, we identified 439 differentially expressed proteins, including 20 members of the immunoglobulin superfamily. Among these candidates, we focused on Negr1, a poorly described cell adhesion molecule. We demonstrated that Negr1 controls the development of neurite arborization in vitro and in vivo. Given the tight correlation existing among synaptic cell adhesion molecules, neuron maturation, and a number of neurological disorders, our assay results are a useful tool that can be used to support the understanding of the molecular bases of physiological and pathological brain function.

1 June 2014 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
GPGiovanni Piccoli
Giovanni Piccoli
FOFranco Onofri
Franco Onofri
MCMaria Daniela Cirnaru
Maria Daniela Cirnaru
CKChristoph J. O. Kaiser
Christoph J. O. Kaiser
PJPravin Kumar Ankush Jagtap
Pravin Kumar Ankush Jagtap
CGChristian Johannes Gloeckner
Christian Johannes Gloeckner
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial and sporadic Parkinson9s disease (PD). LRRK2 is a complex protein that consists of multiple domains, including predicted C-terminal WD40 repeats. In this study, we analyzed functional and molecular features conferred by the WD40 domain. Electron microscopic analysis of the purified LRRK2 C-terminal domain revealed doughnut-shaped particles, providing experimental evidence for its WD40 fold. We demonstrate that LRRK2 WD40 binds and sequesters synaptic vesicles via interaction with vesicle-associated proteins. In fact, a domain-based pulldown approach combined with mass spectrometric analysis identified LRRK2 as being part of a highly specific protein network involved in synaptic vesicle trafficking. In addition, we found that a C-terminal sequence variant associated with an increased risk of developing PD, G2385R, correlates with a reduced binding affinity of LRRK2 WD40 to synaptic vesicles. Our data demonstrate a critical role of the WD40 domain within LRRK2 function.

18 March 2014 in Genome Research
Verified
Journal Article
Open access
PDF file
DSDerek Spieler
Derek Spieler
MKMaria Kaffe
Maria Kaffe
FKFranziska Knauf
Franziska Knauf
JBJose Bessa
Jose Bessa
JTJuan Tena
Juan Tena
JWJuliane Winkelmann
Juliane Winkelmann
Genome-wide association studies (GWAS) identified the MEIS1 locus for Restless Legs Syndrome (RLS), but causal single nucleotide polymorphisms (SNPs) and their functional relevance remain unknown. This locus contains a large number of highly conserved noncoding regions (HCNRs) potentially functioning as cis-regulatory modules. We analyzed these HCNRs for allele-dependent enhancer activity in zebrafish and mice and found that the risk allele of the lead SNP rs12469063 reduces enhancer activity in the Meis1 expression domain of the murine embryonic ganglionic eminences (GE). CREB1 binds this enhancer and rs12469063 affects its binding in vitro. In addition, MEIS1 target genes suggest a role in the specification of neuronal progenitors in the GE, and heterozygous Meis1-deficient mice exhibit hyperactivity, resembling the RLS phenotype. Thus, in vivo and in vitro analysis of a common SNP with small effect size showed allele-dependent function in the prospective basal ganglia representing the first neurodevelopmental region implicated in RLS.

10 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FGFlorian Giesert
Florian Giesert
AHAndreas Hofmann
Andreas Hofmann
ABAlexander Bürger
Alexander Bürger
JZJulia Zerle
Julia Zerle
KKKarina Kloos
Karina Kloos
WWWolfgang Wurst
Wolfgang Wurst
Missense mutations in the leucine-rich repeat kinase 2 gene ( LRRK2 ) are linked to autosomal dominant forms of Parkinson’s disease (PD). In order to get insights into the physiological role of Lrrk2 , we examined the distribution of Lrrk2 mRNA and different splice variants in the developing murine embryo and the adult brain of Mus musculus. To analyse if the Lrrk2 -paralog, Lrrk1, may have redundant functions in PD-development, we also compared Lrrk1 and Lrrk2 expression in the same tissues. Using radioactive in situ hybridization, we found ubiquitous expression of both genes at low level from embryonic stage E9.5 onward, which progressively increased up until birth. The developing central nervous system (CNS) displayed no prominent Lrrk2 mRNA signals at these time-points. However, in the entire postnatal brain Lrrk2 became detectable, showing strongest level in the striatum and the cortex of adult mice; Lrrk1 was only detectable in the mitral cell layer of the olfactory bulb. Thus, due to the non-overlapping expression patterns, a redundant function of Lrrk2 and Lrrk1 in the pathogenesis of PD seems to be unlikely. Quantification of Lrrk2 mRNA and protein level in several brain regions by real-time PCR and Western blot verified the striatum and cortex as hotspots of postnatal Lrrk2 expression. Strong expression of Lrrk2 is mainly found in neurons, specifically in the dopamine receptor 1 (DRD1a) and 2 (DRD2)-positive subpopulations of the striatal medium spiny neurons. Finally, we identified 2 new splice-variants of Lrrk2 in RNA-samples from various adult brain regions and organs: a variant with a skipped exon 5 and a truncated variant terminating in an alternative exon 42a. In order to identify the origin of these two splice variants, we also analysed primary neural cultures independently and found cell-specific expression patterns for these variants in microglia and astrocytes.